The Indian pharmaceutical sector has an estimated market value of about US $8 billion. It's at 4th rank in terms of total pharmaceutical production and 13th in terms of value. It is growing at an average rate 7.2% and is expected to grow to US $12 billion by 2010.

Over the last two years the pharmaceutical market value has increased to about US $355 million because of the launch of new products. According to an estimate, 3900 new generic products have been launched in the past two years. These have been by and large launched by big brands in the pharma sector. And in the year 2005 Indian pharmaceutical companies captured around 70% of the domestic market.

Low cost of research over the western countries gives India a potential advantage for future development. The country has an open market policy. The most promising fact about India is a 70 million middle class population with good consumption power.